Display options
Cite
Tinsman AE, Bellis TJ. Hyperinsulinemia/euglycemia and intravenous lipid emulsion therapy for the management of severe amlodipine toxicosis in a cat. Clin Case Rep. 2021;9(12):e05175doi: 10.1002/ccr3.5175.
Tinsman, A. E., & Bellis, T. J. (2021). Hyperinsulinemia/euglycemia and intravenous lipid emulsion therapy for the management of severe amlodipine toxicosis in a cat. Clinical case reports, 9(12), e05175. https://doi.org/10.1002/ccr3.5175
Tinsman, Audrey E, and Bellis, Tara J. "Hyperinsulinemia/euglycemia and intravenous lipid emulsion therapy for the management of severe amlodipine toxicosis in a cat." Clinical case reports vol. 9,12 (2021): e05175. doi: https://doi.org/10.1002/ccr3.5175
Tinsman AE, Bellis TJ. Hyperinsulinemia/euglycemia and intravenous lipid emulsion therapy for the management of severe amlodipine toxicosis in a cat. Clin Case Rep. 2021 Dec 07;9(12):e05175. doi: 10.1002/ccr3.5175. eCollection 2021 Dec. PMID: 34934496; PMCID: PMC8650752.
Copy Download .nbib Format: NLM
Share it on

Clin Case Rep. 2021 Dec 07;9(12):e05175. doi: 10.1002/ccr3.5175. eCollection 2021 Dec.

Hyperinsulinemia/euglycemia and intravenous lipid emulsion therapy for the management of severe amlodipine toxicosis in a cat.

Clinical case reports

Audrey E Tinsman, Tara J Bellis

Affiliations

  1. BluePearl Specialty + Emergency Pet Hospital New York NY USA.
  2. Emergency & Critical Care Garden State Veterinary Services Iselin NJ USA.

PMID: 34934496 PMCID: PMC8650752 DOI: 10.1002/ccr3.5175

Abstract

Calcium-channel blockers (CCBs) are widely used in people and animals. Overdose can result in cardiovascular collapse and death. Hyperinsulinemia/euglycemia therapy (HIET) and intralipid therapy (ILT) are reported treatment options in people. This is the first report describing HIET and ILT as treatments for amlodipine toxicosis in a cat.

© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Keywords: amlodipine toxicosis; feline; hyperinsulinemia; intralipid therapy; refractory hypotension

Conflict of interest statement

The authors declare no conflicts of interest.

References

  1. J Pharmacol Exp Ther. 1993 Nov;267(2):744-50 - PubMed
  2. Circulation. 1999 Feb 2;99(4):578-88 - PubMed
  3. Hum Exp Toxicol. 2021 Apr;40(4):695-706 - PubMed
  4. Cardiovasc Toxicol. 2018 Jun;18(3):290-293 - PubMed
  5. Ann Emerg Med. 1997 Jun;29(6):748-57 - PubMed
  6. J Vet Emerg Crit Care (San Antonio). 2013 May-Jun;23(3):321-7 - PubMed
  7. Thorac Cardiovasc Surg. 1986 Oct;34(5):305-9 - PubMed
  8. J Feline Med Surg. 2017 Aug;19(8):831-840 - PubMed
  9. J Feline Med Surg. 2019 Dec;21(12):1102-1110 - PubMed
  10. J Vet Emerg Crit Care (San Antonio). 2017 Sep;27(5):561-568 - PubMed
  11. J Cardiovasc Pharmacol. 1988;12 Suppl 7:S55-9 - PubMed
  12. Crit Care Med. 2017 Mar;45(3):e306-e315 - PubMed
  13. Cardiovasc Toxicol. 2017 Oct;17(4):482-486 - PubMed
  14. Daru. 2014 Apr 08;22(1):36 - PubMed
  15. J Vet Intern Med. 2017 Jan;31(1):15-21 - PubMed
  16. J Am Vet Med Assoc. 2009 Jun 1;234(11):1398-403 - PubMed
  17. Clin Toxicol (Phila). 2007 May;45(4):396-401 - PubMed
  18. J Vet Emerg Crit Care (San Antonio). 2011 Aug;21(4):309-20 - PubMed
  19. Clin Toxicol (Phila). 2019 Nov;57(11):1073-1079 - PubMed
  20. Front Vet Sci. 2021 Jun 29;8:668688 - PubMed
  21. Clin Toxicol (Phila). 2011 Apr;49(4):277-83 - PubMed
  22. J Feline Med Surg. 2009 Oct;11(10):783-92 - PubMed
  23. Clin Toxicol (Phila). 2020 Nov;58(11):1042-1049 - PubMed
  24. Vet Clin North Am Small Anim Pract. 2018 Nov;48(6):943-957 - PubMed
  25. Crit Care. 2006;10(3):212 - PubMed

Publication Types